Company lists
The Maharashtra edition · 2026

Diversified pharmaceuticalscompanies in Maharashtra

Generic drugs, CDMO & outsourcing, nutraceuticals & wellness, listed, startups and more: the companies building diversified pharmaceuticals in Maharashtra, with their founders, funding, team size and business models.

80 company profiles45 with reported revenue1 with recorded fundingOctober 2026 edition
Maharashtra · Photo: Wikimedia Commons (Creative Commons Attribution-ShareAlike 4.0)

Recent diversified pharmaceuticals business events in India

Funding, M&A, contract wins and launches involving 423 diversified pharmaceuticals companies in India, last 24 months: 43 M&A deals · 15 Contracts · 9 funding rounds · 5 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.

M&AAcquisition · Announced

Zydus lifesciences acquires Assertio

Paul, Weiss is advising Zydus Lifesciences Limited, an India-based global life sciences company, its acquisition of a U.S.-based pharmaceutical company focused on specialty and…

Pharmaceutical
M&AAcquisition · Announced

Torrent pharma acquires JB Chemicals & Pharma (JBCP)

The acquisition of JB Chemicals & Pharma (JBCP) appears strategically compelling, making it the 5th largest player in the domestic pharma market.

Pharma
M&AAcquisition · Announced

Zydus lifesciences acquires Assertio Holdings

Zydus Lifesciences will acquire US-based Assertio Holdings in an all-cash transaction valued at around $166.4 million, as the Indian drugmaker steps up its presence in specialty…

Pharmaceutical
M&AAcquisition · Completed

Piramal Pharma acquires Kenalog

Piramal Pharma recently completed the Kenalog acquisition

Pharmaceutical
ContractSupply

Panacea biotec · client: Central Medical Services Society (CMSS)

Panacea Biotec has announced the receipt of a Letter of Award from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. The…

Healthcare
FundingSeed

Virchow

Virchow Medical, Inc., manufacturer of the Crow’s Nest® Biopsy Catchment System and operator of the Virchow VaultTM Liquid Specimen Biorepository, today announced it has completed a $4…

Investors Cerberus Ventures, Pathologists and interventional radiologists
Healthcare
LaunchSembolic

Torrent pharmaceuticals

Torrent Pharmaceuticals Limited (NSE: TORNTPHARM | BSE: 500420) has entered India’s newly opened glucagon-like peptide-1 therapy market with a dual-format semaglutide launch, becoming…

Glucagon-like peptide-1 (GLP‑1) injectable therapy
ContractSupply

Lupin · client: Zydus lifesciences

Shares of Lupin and Zydus Lifesciences rose up to 2% on Tuesday after the pharma firm inked a licensing and supply agreement with the lifesciences company, to expand access to innovative…

Funding

Vilin Bio Med

This agreement outlines a ₹100 Crore investment to establish a state-of-the-art Medical Devices Manufacturing facility.

Pharmaceuticals
ContractSupply

Panacea Biotech · client: Unicef

Panacea Biotech received a letter of award under a long-term agreement to supply bivalent oral polio vaccine (bOPV) in 10-vial and 20-vial packs.

Healthcare
FundingMinority equity financing round

Plasmagen biosciences

PlasmaGen Biosciences, a leading biopharmaceutical company focussed on blood plasma-derived therapeutics, announced that it has raised Rs 150 crores in a minority equity financing round…

Biopharmaceutical
ContractSupply

Panacea biotec · client: Unicef

Earlier in October, UNICEF also placed a significant order for polio vaccines. Panacea Biotec received the letter of award (LoA) as part of a long-term agreement to supply bOPV in 10 and…

Healthcare
ContractSupply

Pfizer India · client: Cipla Ltd

Cipla Ltd has inked an exclusive agreement with Pfizer India to market, distribute, and sell the latter's four brands across the country.

Pharmaceutical
M&AAcquisition · Announced

Nowonomics acquires Centaur

On Wednesday, Dec. 10, it was announced that Swedish fund management company Centaur is selling its Sweden Quality fund to Nowonomics.

Fund management
FundingSeries A

Alembic

Alembic has raised $145 million in new funding led by Prysm Capital and Accenture, with participation from Silver Lake Waterman, WndrCo, and other investors.

Investors Prysm capital, Accenture, Silver Lake Waterman, Wndrco
Causal AI
M&AAcquisition · Announced

Mankind pharma acquires Bharat Serums and Vaccines

Drug maker Mankind Pharma Ltd on Friday said it has executed a Business Transfer Agreement with its wholly owned subsidiary, Bharat Serums and Vaccines Limited , for the acquisition of…

Pharmaceutical
ContractService

Glenmark pharmaceuticals · client: Abbvie

Glenmark Pharma Share Price: Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with AbbVie to commmercialise its…

Pharma
M&AAcquisition · Completed

Emcure pharmaceuticals acquires Zuventus healthcare

Emcure Pharmaceuticals said it will acquire the remaining 20.42 per cent stake in its arm Zuventus Healthcare Ltd from minority shareholders for Rs 724.9 crore.

Pharmaceutical
ContractService

Agenus · client: Zydus lifesciences

Agenus Inc. (NASDAQ: AGEN) has entered into a $141 million agreement with Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE) to accelerate the clinical development and manufacturing of its lead…

Biopharmaceutical
M&AMerger · Announced

Sparc acquires Jcpenney

Around the time of the sale to Galaxy, Sparc and JCPenney announced they were combining to create a new retail umbrella group, Catalyst Brands.

ContractService

OMD India · client: Piramal Pharma

Piramal Pharma has awarded its integrated media mandate to OMD India, part of Omnicom Media Group.

Advertising
LaunchLatanoprost Ophthalmic Solution, 0.005 per cent

Glenmark pharmaceuticals

Glenmark Pharmaceuticals Inc., USA announced today the launch of Latanoprost Ophthalmic Solution, 0.005 per cent, a generic version of Upjohn’s Xalatan.

Ophthalmic
FundingPrivate placement

Centaur pharmaceuticals

Centaur Pharmaceuticals Inc. raised $20.1 million in a private placement of 1.9 million shares of common stock.

Pharmaceuticals
M&AAcquisition · Announced

Mankind pharma acquires Bsv group

Advent International's $1.6 billion sale of BSV Group to Mankind Pharma

LaunchBrand Health Daily Sentiment Tool

Alembic

Alembic, the leading AI-powered marketing intelligence platform for enterprises, today announced the preview release of its Brand Health Daily Sentiment Tool.

Diversified pharmaceuticals companies in Maharashtra, by revenue

Browse diversified pharmaceuticals companies in Maharashtra by reported revenue, one-year revenue growth, revenue model, age and stage. The 45 companies below are the largest by their most recent reported revenue among 45 diversified pharmaceuticals companies in Maharashtra that have filed a figure in the last four years. Every figure keeps its own reporting period, so compare periods before comparing amounts.

Showing 25 of 45

R&D company focused on manufacturing generic drugs for multiple therapeutic areas

Diversified pharmaceuticals
₹12,653.09 crFY 2023-24
Not reported
15,922+9% 12 mo to Mar 2024LinkedIn · Oct 2026
49 yr1977
19postings · last posted Sep 2026

Diversified pharmaceutical company offering a portfolio of innovative healthcare solutions through end-to-end manufacturing capabilities

Diversified pharmaceuticals
₹9,285.99 crFY 2024-25
+11%2024–2025
2,964LinkedIn · Oct 2026
6 yr2020
25postings · last posted Oct 2026

Manufacturer of OTC, vitamin & mineral supplements, and chemical products

Diversified pharmaceuticals
₹1,248.01 crFY 2022-23
Not reported
1+0% 12 mo to Sep 2024recorded Sep 2024
59 yr1967
—No postings tracked

R&D company focused on manufacturing drugs for multiple therapeutic areas

Diversified pharmaceuticals
₹1,117.95 crFY 2024-25
+4%2024–2025
2,752-0% 12 mo to Sep 2024LinkedIn · Oct 2026
24 yr2002
0none in 3 months

R&D company focused on manufacturing drugs for multiple therapeutics areas

Diversified pharmaceuticals
₹619.33 crFY 2024-25
+23%2024–2025
750recorded
15 yr2011
0none in 3 months

Develops, produces, and commercializes biotherapeutics for life-threatening diseases across various indications

Diversified pharmaceuticals
₹432.25 crFY 2024-25
+2%2024–2025
821+2% 12 mo to Aug 2023LinkedIn · Oct 2026
20 yr2006
0none in 3 months · last posted Jun 2026

Manufacturer of tablets and capsules along with generic products

Diversified pharmaceuticals
₹214.78 crFY 2024-25
+13%2024–2025
259+12% 12 mo to Sep 2024recorded Sep 2024
12 yr2014
0none in 3 months

Pharmaceutical company focused on providing healthcare solutions worldwide

Diversified pharmaceuticals
₹195.24 crFY 2024-25
+56%2024–2025
271LinkedIn · Jul 2026
34 yr1992
2postings · last posted Sep 2026

Manufacturer of pharmaceutical products for multiple therapeutic areas

Diversified pharmaceuticals
₹162.97 crFY 2024-25
-15%2024–2025
23+0% 12 mo to Sep 2024recorded Sep 2024
22 yr2004
0none in 3 months

R&D company manufacturing drugs for multiple therapeutic areas

Diversified pharmaceuticals
₹115.25 crFY 2024-25
+6%2024–2025
148-2% 12 mo to Sep 2024LinkedIn · Oct 2026
16 yr2010
0none in 3 months · last posted Apr 2026

Manufacturer of generics, APIs across multiple therapeutic segments.

Diversified pharmaceuticals
₹108.59 crFY 2022-23
Not reported
286-21% 12 mo to Mar 2024LinkedIn · Jul 2026
80 yr1946
0none in 3 months · last posted May 2026

Manufacturer of pharmaceutical formulations, herbal remedies, and cosmeceuticals

Alternative medicine products
₹91.31 crFY 2024-25
-30%2024–2025
167+1% 12 mo to Sep 2024recorded Sep 2024
22 yr2004
0none in 3 months

R&D company focused on manufacturing drugs for multiple therapeutic areas

Diversified pharmaceuticals
₹82.49 crFY 2024-25
+41%2024–2025
3+0% 12 mo to May 2020recorded May 2020
24 yr2002
0none in 3 months

Manufacturer of pharmaceuticals, orthopedics, oncology products, and advanced wound care

Diversified pharmaceuticals
₹75.37 crFY 2024-25
+13%2024–2025
58LinkedIn · Jul 2026
18 yr2008
0none in 3 months

R&D based pharmaceutical company specializing in the manufacturing, distribution, and export of pharmaceutical formulations and APIs

Diversified pharmaceuticals
₹65.37 crFY 2021-22
Not reported
59+7% 12 mo to Sep 2024recorded Sep 2024
67 yr1959
—No postings tracked

Developer of therapies for treating cancer and inflammatory diseases

Diversified pharmaceuticals
₹73.56 crFY 2024-25
-30%2024–2025
702-14% 12 mo to Sep 2024LinkedIn · Oct 2026
20 yr2006
0none in 3 months

Specialty company developing products for autoimmune, CNS, Infectious and lifestyle diseases

Diversified pharmaceuticals
₹71.42 crFY 2024-25
+2%2024–2025
164-3% 12 mo to Jun 2023LinkedIn · Jul 2026
29 yr1997
0none in 3 months

Manufacturer of generic solid and liquid dosage forms

Traditional pharmaceuticals
₹71.31 crFY 2024-25
+30%2024–2025
13+6% 12 mo to Sep 2024LinkedIn · Oct 2026
29 yr1997
0none in 3 months

Provider of turnkey solutions for biscuit and confectionery production lines

Diversified pharmaceuticals
₹62.56 crFY 2024-25
+10%2024–2025
60LinkedIn · Jul 2026
24 yr2002
1postings · last posted Sep 2026

Diversified pharmaceutical company

Diversified pharmaceuticals
₹59.81 crFY 2024-25
+3%2024–2025
146-14% 12 mo to Sep 2024recorded Sep 2024
7 yr2019
0none in 3 months

Manufacturer of orthopedic products including supports and bandages for joint pain

Diversified pharmaceuticals
₹57.23 crFY 2024-25
+57%2024–2025
53LinkedIn · Jul 2026
28 yr1998
0none in 3 months

Pharmaceutical company, manufacturing a range of injectable products, including contrast media, with a focus on quality and compliance with international standards

Biopharma outsourcing
₹51.27 crFY 2024-25
+12%2024–2025
39-2% 12 mo to Mar 2024LinkedIn · Jul 2026
22 yr2004
0none in 3 months

Provider of pharmaceutical products for orthopaedics, gynaecology, pain, and inflammation

Diversified pharmaceuticals
₹49.64 crFY 2024-25
+13%2024–2025
222+3% 12 mo to Jul 2024recorded Jul 2024
7 yr2019
0none in 3 months

Pharmaceutical company providing quality medicines at reasonable prices

Diversified pharmaceuticals
₹45.47 crFY 2024-25
-4%2024–2025
195LinkedIn · Jul 2026
10 yr2016
1postings · last posted Aug 2026

Pharmaceutical company that develops and manufactures a wide range of dosage forms, including tablets, capsules, and injectables

Diversified pharmaceuticals
₹44.76 crFY 2024-25
+54%2024–2025
—Not available
13 yr2013
0none in 3 months
45 of 80 companies shown here · the full list is on Radar
Fliar Radar

Explore all 80 diversified pharmaceuticals companies in Maharashtra on Radar

This page shows the top 45. Radar has the complete, filterable list with contacts and live company signals.

Open diversified pharmaceuticals in Maharashtra on Radar
  • Every company, not just 50All 80 diversified pharmaceuticals companies in Maharashtra, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore diversified pharmaceutical companies in Maharashtra by what you are looking for

Browse diversified pharmaceutical companies in Maharashtra, from generic drug makers to contract development and manufacturing firms. Find diversified pharma companies that cover many therapeutic areas.

6 ways to explore diversified pharmaceuticals in Maharashtra

Generic drug & formulation manufacturersContract manufacturing, CDMO & biopharma outsourcingNutraceutical, supplement & herbal product makersListed pharmaceutical companies in MaharashtraPharmaceutical startups in MaharashtraPharmaceutical companies hiring in Maharashtra

Generic drug & formulation manufacturers

Manufacturers of generic medicines and branded formulations across therapeutic areas.

  1. Glenmark Pharmaceuticals

    R&D company focused on manufacturing generic drugs for multiple therapeutic areas

    Diversified pharmaceuticals
    See in list
  2. Piramal Pharma

    Diversified pharmaceutical company offering a portfolio of innovative healthcare solutions through end-to-end manufacturing capabilities

    Diversified pharmaceuticals
    See in list
  3. Procter & Gamble Health

    Manufacturer of OTC, vitamin & mineral supplements, and chemical products

    Diversified pharmaceuticals
    See in list
  4. Centaur

    Developer and manufacturer of branded formulations as well as APIs

    Biopharma outsourcing
    Website
  5. Gennova

    Develops, produces, and commercializes biotherapeutics for life-threatening diseases across various indications

    Diversified pharmaceuticals
    See in list

Contract manufacturing, CDMO & biopharma outsourcing

Companies offering contract development, manufacturing and research services for drug makers.

  1. Centaur

    Developer and manufacturer of branded formulations as well as APIs

    Biopharma outsourcing
    Website
  2. Indus Biotech

    Specialty company developing products for autoimmune, CNS, Infectious and lifestyle diseases

    Diversified pharmaceuticals
    See in list
  3. Arco Lifesciences

    Pharmaceutical company, manufacturing a range of injectable products, including contrast media, with a focus on quality and compliance with international standards

    Biopharma outsourcing
    See in list
  4. Epygen Biotech

    Manufacturer of therapeutic proteins for oncology, cardiovascular, immune disorders, and vaccines

    Diversified pharmaceuticals
    Website

Nutraceutical, supplement & herbal product makers

Makers of dietary supplements, herbal remedies and women's health products.

  1. Orbit Lifescience

    Manufacturer of pharmaceutical products for multiple therapeutic areas

    Diversified pharmaceuticals
    See in list
  2. Sydler India

    Manufacturer of pharmaceutical formulations, herbal remedies, and cosmeceuticals

    Alternative medicine products
    See in list
  3. Blisson

    Provider of pharmaceutical products for orthopaedics, gynaecology, pain, and inflammation

    Diversified pharmaceuticals
    See in list

Listed pharmaceutical companies in Maharashtra

Publicly traded diversified pharmaceutical companies in Maharashtra.

  1. Glenmark Pharmaceuticals

    R&D company focused on manufacturing generic drugs for multiple therapeutic areas

    Diversified pharmaceuticals
    See in list
  2. Piramal Pharma

    Diversified pharmaceutical company offering a portfolio of innovative healthcare solutions through end-to-end manufacturing capabilities

    Diversified pharmaceuticals
    See in list
  3. Procter & Gamble Health

    Manufacturer of OTC, vitamin & mineral supplements, and chemical products

    Diversified pharmaceuticals
    See in list
  4. SPARC

    Developer of therapies for treating cancer and inflammatory diseases

    Diversified pharmaceuticals
    See in list
  5. Sanjivani Parenteral

    Manufacturer of generic solid and liquid dosage forms

    Traditional pharmaceuticals
    See in list
7 companies in Maharashtra

Pharmaceutical startups in Maharashtra

Newer pharmaceutical companies founded in recent years.

  1. Scintel Pharmachem

    Provider of contract research and manufacturing solutions for pharmaceutical products

    Diversified pharmaceuticals
    See in list
  2. Luminia Lifecare

    R&D company focused on manufacturing drugs for multiple therapeutic areas

    Diversified pharmaceuticals
    Website
  3. Clatan

    Company offering medicine and offers a portfolio of healthcare products

    Diversified pharmaceuticals
    Website
  4. Starkvast

    A provider of high-grade quality medicines, addressing unmet medical needs

    Diversified pharmaceuticals
    Website
  5. Jupiter Formulations

    Pharmaceutical company that specializes in the development and manufacturing of medicines

    Diversified pharmaceuticals
    Website
8 companies in Maharashtra

Pharmaceutical companies hiring in Maharashtra

Diversified pharmaceutical companies in Maharashtra with open roles.

  1. Glenmark Pharmaceuticals

    R&D company focused on manufacturing generic drugs for multiple therapeutic areas

    Diversified pharmaceuticals
    See in list
  2. Piramal Pharma

    Diversified pharmaceutical company offering a portfolio of innovative healthcare solutions through end-to-end manufacturing capabilities

    Diversified pharmaceuticals
    See in list
  3. Gennova

    Develops, produces, and commercializes biotherapeutics for life-threatening diseases across various indications

    Diversified pharmaceuticals
    See in list
  4. Galentic Pharma

    Pharmaceutical company focused on providing healthcare solutions worldwide

    Diversified pharmaceuticals
    See in list
  5. VHB Life Sciences

    Manufacturer of generics, APIs across multiple therapeutic segments.

    Diversified pharmaceuticals
    See in list
8 companies in Maharashtra
The business behind the activity

Diversified pharmaceuticals financials in Maharashtra

Revenue, profit and growth from the filed annual accounts of 46 diversified pharmaceuticals companies in Maharashtra for FY24-25 — 53 of the 80 companies on this page file accounts with the Ministry of Corporate Affairs. The five largest earn 88% of the revenue, so medians describe the typical company better than totals.

combined revenue, FY24-25₹25,440.53 cr

46 companies filing accounts

combined net profit₹3,931.31 cr

15.5% aggregate margin

are profitable83%

38 of 46 companies

median revenue~₹49.7 cr

the typical company

median revenue growth+8%

into FY24-25

earned by the top five88%

revenue concentration

Six-year view

Combined revenue of filing companies

₹16,386.88 crFY19-2046 filers
₹16,680.22 crFY20-2149 filers
₹22,231.04 crFY21-2250 filers
₹23,790.55 crFY22-2349 filers
₹23,173.63 crFY23-2449 filers
₹25,440.53 crFY24-2546 filers

The number of companies filing changes each year; the three-year cohort below compares like with like.

Like-for-like

The same 44 companies over three years

+13%
FY22-23₹22,468.66 cr₹2,570.37 cr net
FY23-24₹23,091.37 cr₹6,884.72 cr net
FY24-25₹25,381.98 cr₹3,930.72 cr net

Companies with accounts for all three years, so growth is not an artefact of who filed.

Scale and profit

Bigger companies are far more often profitable

Under ₹1 cr250% profitable
₹1–10 cr450% profitable
₹10–100 cr2889% profitable
₹100–1,000 cr771% profitable
Over ₹1,000 cr5100% profitable

Companies by FY24-25 revenue. Bars show how many companies sit in each band.

Momentum

How fast revenue moved into FY24-25

Shrinking13
0–20%19
20–50%8
50–100%4
Doubled+2

46 companies with accounts for both years; median growth +8%.

Profitability

Profit is concentrated at the top

38profitable
8loss-making
15.5%aggregate margin
3.2%median margin

The aggregate margin is pulled up by a few large filers; the median shows the typical company.

Growth leaders · ₹10 cr+ revenue

Fastest growing, FY24-25

CompanyGrowthRevenue
Agati HealthcareAgati Healthcare Private Limited+218%₹11.87 cr
Epygen BiotechEPYGEN BIOTECH PRIVATE LIMITED+138%₹23.61 cr
Lords Mark BiotechLORDS MARK BIOTECH PRIVATE LIMITED+57%₹57.23 cr
Galentic PharmaGALENTIC PHARMA INDIA PVT LTD+56%₹195.11 cr
Pharmax IndiaPHARMAX INDIA PRIVATE LIMITED+55%₹103.00 cr
Ahaan HealthcareAHAAN HEALTHCARE PRIVATE LIMITED+54%₹44.76 cr
Profit leaders · ₹10 cr+ revenue

Highest net margins, FY24-25

CompanyMarginRevenue
Epygen BiotechEPYGEN BIOTECH PRIVATE LIMITED₹23.61 cr
USVUSV PRIVATE LIMITED28.4%
Galentic PharmaGALENTIC PHARMA INDIA PVT LTD23.8%₹195.11 cr
Virchow HealthcareVIRCHOW HEALTHCARE PRIVATE LIMITED23.6%₹75.37 cr
Ahaan HealthcareAHAAN HEALTHCARE PRIVATE LIMITED23.0%₹44.76 cr
CentaurCENTAUR PHARMACEUTICALS PRIVATE LIMITED₹1,060.17 cr
Inside the industry

Sub-sectors compared, FY24-25

Sub-sectorCompaniesRevenueMedian revenueProfitableMargin
Diversified pharmaceuticals40₹24,125.60 cr~₹47.6 cr80%15.4%
Leaders

Largest diversified pharmaceuticals companies by revenue, FY24-25

Company · legal entityRevenueNet resultMarginGrowth
Glenmark PharmaceuticalsGLENMARK PHARMACEUTICALS LIMITED₹9,582.77 cr₹1,610.35 cr16.8%+6%
Piramal PharmaPIRAMAL PHARMA LIMITED₹5,493.06 cr₹691.40 cr12.6%+20%
USVUSV PRIVATE LIMITED₹1,457.17 cr28.4%+8%
ZuventusZUVENTUS HEALTHCARE LIMITED₹1,117.95 cr₹134.78 cr12.1%+4%
CentaurCENTAUR PHARMACEUTICALS PRIVATE LIMITED₹1,060.17 cr₹189.99 cr+22%
Bayer Zydus PharmaBAYER ZYDUS PHARMA PRIVATE LIMITED₹619.33 cr₹56.10 cr9.1%+23%
GennovaGENNOVA BIOPHARMACEUTICALS LIMITED₹432.25 cr−₹11.52 cr-2.7%+2%
Qualigens PharmaQUALIGENS PHARMA PRIVATE LIMITED₹214.78 cr₹30.11 cr14.0%+13%
Galentic PharmaGALENTIC PHARMA INDIA PVT LTD₹195.11 cr₹46.41 cr23.8%+56%
Orbit LifescienceORBIT LIFESCIENCE PRIVATE LIMITED₹162.97 cr₹61.49 lakh0.4%-15%
Some figures are available to Radar members.Log in to Radar to see every figure

Standalone annual accounts filed with the Ministry of Corporate Affairs. Brands that share one legal entity are shown together and counted once.

For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding and MCA filings data. Use it through the Investor Intelligence API and MCA financials feeds, or explore every company, filing and investor in Radar.

Capital & corporate activity

Diversified pharmaceuticals funding and M&A across India

60 recorded equity rounds have gone to 423 diversified pharmaceuticals companies in India — how much, at which stage, into which sub-sectors, from whom, and how Maharashtra compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months2

US$16.78m

equity rounds, last 24 months3

US$41.78m

raised over five yearsUS$141.88m

16 rounds in India

M&A deals, India43

last 24 months

Capital by year

Equity funding into diversified pharmaceuticals in India

amount rounds
$5.1m20183
$41m20195
$9.7m20205
$20m20216
$9.2m20222
$27m20231
$44m20244
$42m20252
$44k20261

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2024, with US$44.06m across 4 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$404k1 rounds · median US$404k
SeedUS$16.29m3 rounds · median US$8.14m
Series AUS$5.64m5 rounds · median US$1.21m
Series BUS$21.90m2 rounds · median US$10.95m
Series CUS$60.91m3 rounds · median US$25.00m
Series D+US$16.73m1 rounds · median US$16.73m
Private equityUS$20.00m1 rounds · median US$20.00m
Where the money went · five years

Most-funded sub-sectors

Diversified pharmaceuticalsUS$141.83m15 rounds · 7 companies
Diversified diagnosticsUS$44k1 rounds · 1 companies
Corporate activity · last 24 months

M&A in India

40Acquisition
3Merger

Most active acquirers

  1. Torrent pharmaceuticals28
  2. Zydus lifesciences7
  3. Mankind pharma3
  4. Piramal Pharma1
  5. Nowonomics1

Most acquired or merged

  1. JB Chemicals3
  2. JB Chemicals & Pharmaceuticals2
  3. Bharat Serums and Vaccines2
  4. Jb Pharma2
  5. Amplitude surgical2

Each deal appears in the events strip at the top of the page.

Founders and momentum in Maharashtra

Meet the people behind diversified pharmaceuticals companies in Maharashtra. 31 of 80 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Maharashtra diversified pharmaceuticals companies by sub-sector

The most common specialisations among diversified pharmaceuticals companies in Maharashtra. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring diversified pharmaceuticals in India and nearby markets.

Coming soon